Helena Nordin Rudberg
Algemeen Directeur bij Crane Ridge Pharma Consulting AB
Profiel
Ms. Helena Nordin Rudberg is Chairman & Chief Executive Officer at Crane Ridge Pharma Consulting AB.
She is on the Board of Directors at Serendex Pharmaceuticals A/S, Reyholmia AB, and Swedish Investment Development Organization AB.
Ms. Rudberg was previously employed as Executive Vice President-Sales & Marketing by Biovitrum AB and Head-BU Hemophilia by Swedish Orphan Biovitrum AB.
Actieve functies van Helena Nordin Rudberg
| Bedrijven | Functie | Begin |
|---|---|---|
| Crane Ridge Pharma Consulting AB | Algemeen Directeur | - |
| Reyholmia AB | Directeur/Bestuurslid | - |
| Swedish Investment Development Organization AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Helena Nordin Rudberg
| Bedrijven | Functie | Einde |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Verkoop & Marketing | - |
| SERENDEX PHARMACEUTICALS A/S | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark. | Health Technology |
| Crane Ridge Pharma Consulting AB | |
| Reyholmia AB | |
| Swedish Investment Development Organization AB |
